Clearside Biomedical (CLSD) SEC Filings & 10K Form

$1.25
-0.10 (-7.41%)
(As of 05/10/2024 08:54 PM ET)

Recent Clearside Biomedical SEC Filings

DateFilerForm TypeView
05/09/2024
3:10 PM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:45 PM
Clearside Biomedical (Filer)
Form ARS
04/19/2024
8:45 AM
Clearside Biomedical (Issuer)
Gibney Anthony S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:30 PM
Clearside Biomedical (Issuer)
Gibney Anthony S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2024
3:31 PM
Clearside Biomedical (Issuer)
Gibney Anthony S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
6:15 AM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:30 PM
Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:20 PM
Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:19 PM
Chong Ngai Hang Victor (Reporting)
Clearside Biomedical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2024
4:15 PM
Clearside Biomedical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2024
3:16 PM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
12:00 PM
Clearside Biomedical (Issuer)
WHITMORE BRADFORD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
4:05 PM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
5:25 PM
Clearside Biomedical (Issuer)
Deignan Charles A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:26 PM
Clearside Biomedical (Issuer)
LASEZKAY GEORGE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
2:26 PM
Clearside Biomedical (Subject)
LASEZKAY GEORGE M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/19/2024
2:04 PM
Clearside Biomedical (Subject)
Deignan Charles A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
3:10 PM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
3:30 PM
Clearside Biomedical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2023
11:01 AM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
3:24 PM
Clearside Biomedical (Issuer)
WHITMORE BRADFORD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:06 PM
Clearside Biomedical (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
3:46 PM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:34 PM
Clearside Biomedical (Issuer)
Thorp Clay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:35 PM
Clearside Biomedical (Issuer)
Humphries William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:29 PM
Clearside Biomedical (Issuer)
LASEZKAY GEORGE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:30 PM
Clearside Biomedical (Issuer)
Deignan Charles A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
5:55 PM
Clearside Biomedical (Issuer)
Deignan Charles A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:31 PM
Clearside Biomedical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/23/2023
3:37 PM
Clearside Biomedical (Issuer)
SHAFFER CHRISTY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:38 PM
Clearside Biomedical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:38 PM
Clearside Biomedical (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:38 PM
Clearside Biomedical (Issuer)
Humphries William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:39 PM
Clearside Biomedical (Issuer)
EDWARDS JEFFREY L (Reporting)
EDWARDS JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:40 PM
Clearside Biomedical (Issuer)
Clearside Biomedical (Issuer)
Croarkin Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:41 PM
Clearside Biomedical (Issuer)
Thorp Clay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:36 PM
Clearside Biomedical (Issuer)
YERXA BENJAMIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:15 PM
Clearside Biomedical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2023
11:15 PM
Clearside Biomedical (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CLSD) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners